The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

医学 全身疗法 阶段(地层学) 肺癌 回顾性队列研究 外科 内科学 癌症 全身性疾病 疾病 生物 古生物学 乳腺癌
作者
Pieter J.M. Joosten,Adrianus J. de Langen,Vincent van der Noort,Kim Monkhorst,Houke M. Klomp,A.A.F.A. Veenhof,Chris Dickhoff,Egbert F. Smit,Koen J. Hartemink
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:161: 141-151 被引量:9
标识
DOI:10.1016/j.lungcan.2021.09.019
摘要

Objectives: Patients with advanced stage non-small cell lung cancer (NSCLC) are generally considered incurable.The mainstay of treatment for these patients is systemic therapy.The addition of local treatment, including surgery, remains controversial.Oligoprogression is defined as advanced stage NSCLC with limited progression of disease after a period of prolonged disease stabilisation or after a partial or complete response on systemic therapy.In this retrospective study we evaluated outcome and survival of patients who underwent a resection for oligoprogression after systemic therapy for advanced stage NSCLC.Materials and Methods: Patients with oligoprogression after systemic treatment for advanced NSCLC who were operated in the Antoni van Leeuwenhoek Hospital were included.Patient and treatment characteristics were collected in relation to progression free survival (PFS) and overall survival (OS).Results: Between January 2015 and December 2019, 28 patients underwent surgery for an oligoprogressive lesion (primary tumor lung (n = 12), other metastatic site (n = 16)).Median age at time of resection was 60 years (39-86) and 57% were female.Postoperative complications were observed in 2 patients (7%).Progression of disease after resection of the oligoprogressive site was observed in 17 patients (61%).Median PFS was 7 months since date of resection (95% CI 6.0-25.0)and median OS was not reached.Seven patients (25%) died during follow-up.Age was predictive for OS and clinical T4 stage was predictive for PFS.M1 disease at initial presentation was predictive for better PFS compared to patients who were diagnosed with M0 disease initially.Patients who underwent resection because of oligoprogression of the primary lung tumour had a better PFS, when compared to oligoprogression of another metastastic site.Conclusion: Surgical resection of an oligoprogressive lesion in patients with advanced NSCLC treated with systemic treatment is feasible and might be considered in order to achieve long term survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
呱呱完成签到,获得积分10
刚刚
刚刚
刚刚
傲娇的汉堡完成签到,获得积分10
1秒前
dahuihui发布了新的文献求助10
1秒前
抹颜完成签到,获得积分10
2秒前
2秒前
666发布了新的文献求助10
2秒前
轻松雪旋完成签到,获得积分20
3秒前
完美的冷荷完成签到,获得积分10
3秒前
小李爱学习应助张鱼哥采纳,获得10
3秒前
4秒前
4秒前
CodeCraft应助优美世倌采纳,获得10
5秒前
Y_LH发布了新的文献求助10
5秒前
6秒前
无花果应助含糊的白安采纳,获得10
6秒前
轻松雪旋发布了新的文献求助10
7秒前
舒适的妙旋完成签到,获得积分10
7秒前
jie发布了新的文献求助10
7秒前
7秒前
7秒前
zhao完成签到,获得积分20
7秒前
nini发布了新的文献求助10
7秒前
8秒前
852应助微笑的凌旋采纳,获得20
8秒前
8秒前
8秒前
8秒前
甜甜之卉完成签到,获得积分10
8秒前
哈哈哈完成签到,获得积分20
9秒前
9秒前
无极微光应助六六采纳,获得20
9秒前
苹果朋友完成签到 ,获得积分10
10秒前
10秒前
10秒前
CipherSage应助zzr元亨利贞采纳,获得10
10秒前
123发布了新的文献求助10
10秒前
11秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6540895
求助须知:如何正确求助?哪些是违规求助? 8331863
关于积分的说明 17854851
捐赠科研通 5646769
什么是DOI,文献DOI怎么找? 2936426
邀请新用户注册赠送积分活动 1912511
关于科研通互助平台的介绍 1773529